Viewpoints

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Resource Types

First-in-Human Studies Accelerated with Syngene’s CDMO Model
Discover a smarter approach to first-in-human studies with Syngene, integrating discovery, CMC, manufacturing, and governance to de-risk FIH trials.
Read
Detection and quantitation of process-related impurities in biopharma manufacturing
Learn the challenges in the detection and quantitation of process-related impurities, including nitrosamine and azido impurities, and Syngene’s capabilities and solutions to resolve them.
Read
Holistic, mechanism-driven approach to toxicity assessment using Computational and Data Sciences
Learn how Syngene provides in silico and in vitro support for holistic toxicity assessment using Computational & Data Sciences.
Read
Regulatory role of Biophysics in Biologics CMC
Learn the role of biophysics-driven analytical tools in accurately identifying biologics CQAs and analyzing HOS to make the final product efficacious and safe for patients...
Read
Choosing the ‘right’ CRO-CDMO in Biopharma - What has changed
Learn the new criteria that have emerged as more important for selecting an outsourcing partner consequent to disruptions caused by the COVID-19 pandemic.
Read
How Syngene is implementing Green Chemistry in pharmaceutical development – Design to Delivery
Learn how Syngene is helping pharma companies minimize environmental impact using its Green Chemistry approach to drug development.
Read
Transforming Supply Chain risks into a competitive advantage in the CRO-CDMO space-The Syngene story
Learn how Syngene built a biopharma supply chain that is fast, resilient, and future-proof and, in the process, turned supply chain risks into a competitive...
Read
Intensified Biomanufacturing
Learn how Syngene is achieving three to four-fold higher titers of mAbs using its Intensified Fed-Batch process
Read
Enabling early assessment of drug targets to maximize clinical and commercial success
Comprehensive diligence around a target at the start of a discovery program can make the difference between success and failure. Learn how Syngene’s Target Assessment...
Read
Essential In vivo Safety - Tox studies to move your molecule from Target to IND successfully
Learn about Syngene’s expertise in  Safety/Tox studies that allows us to guide you through the various requirements leading to successful IND submission.
Read

Putting Science to Work Starts Here

Share a few details and our team will reach out to explore how we can support your goals.

To view or email, Please share your details view

Download PDF
Download PDF

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details